PHILADELPHIA.Today on MSN
Wistar to Honor Dr. Svetlana Mojsov Whose Discovery of GLP-1 Protein is Behind Blockbuster Weight-Loss Drugs
The Wistar Institute honors Svetlana Mosjov, Ph.D., as the 2025 Helen Dean King Award recipient. Dr. Mojsov, research ...
Discover the untold story behind the discovery of rapamycin on Easter Island, raising questions about Indigenous rights and ...
Scientists discovered that Gila monster venom contains a compound that slows digestion. It led to one of the biggest medical ...
Ozempic has been approved in India for type 2 diabetes. The blockbuster drug by Danish drugmaker Novo Nordisk has taken the ...
GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...
An appeals court decision striking down claims from a patent for a blockbuster drug that rested on language touting its ...
As in any month, September was eventful for AbbVie. In addition to news about its usual activities, it also scored big with ...
Everyday Health on MSN
Blockbuster Cancer Drug Keytruda Now Available as a Time-Saving Shot
So-called checkpoint proteins on immune cells serve as gatekeepers that are supposed to keep foreign invaders from entering healthy cells. Certain cancers use these checkpoints to avoid detection.
On September 26, Danish pharma multinational Novo Nordisk got the Indian drug regulator Central Drugs Standard Control ...
AstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, Crestor, to German pharmaceutical company Gruenenthal GmbH for an upfront payment of $320 million as the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results